Cancer is no match for our blood, sweat and tears. Which is why we’re testing our endurance to push the needle forward for cancer research.
We are Curestarters for Fred Hutchinson Cancer Research Center because Fred Hutch scientists are world leaders in revolutionizing the way we prevent, detect, and treat cancer and related diseases. To put it simply, their research saves lives.
Did you know ...
The bone marrow transplant, developed by Dr. E. Donnall Thomas at Fred Hutch, earned him a Nobel Prize and provided the first example of the human immune system’s power to cure cancer. More than 1 million people have received this lifesaving procedure.
Today, Drs. Phil Greenberg and Stanley Riddell continue Dr. Thomas’ legacy, leading the way in the game-changing field of immunotherapy. In fact, they are perfecting an approach that could render chemotherapy and radiation obsolete, making cancer treatment for patients much less grueling and toxic.
Dr. Denise Galloway helped develop the vaccine that prevents human papillomavirus, or HPV, infection, which can cause cervical cancer.
Dr. Jim Olson developed “Tumor Paint”, an experimental molecule derived from scorpion venom that illuminates cancer cells so surgeons can see tumor margins more clearly. This means surgeons can zero in on the cancer, eliminating all of it, without affecting healthy tissue.
Dr. Gary Gilliland, president and director of Fred Hutch, has a bold vision. He believes Fred Hutch scientists can find curative therapies for many, if not all, cancers by the year 2025. They just need the funding to do it.
Please join us in supporting this endeavor by donating today — your gift will support innovative research that saves lives.